Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma.
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy*; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000628:therapy*; D004341:Drug Evaluation; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000628:therapy*; D012004:Rectal Neoplasms / Q000628:therapy*; D013274:Stomach Neoplasms / Q000628:therapy*
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal